Pfizer Should Face Lipitor Row In Calif., 3rd Circ. Hears
Pfizer Inc. and Ranbaxy Laboratories Inc. shouldn't have been able to kill a suit by nine pharmacists in multidistrict litigation over Lipitor because the pharmacists sued under California state law, not...To view the full article, register now.
Already a subscriber? Click here to view full article